Status:
COMPLETED
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
Lead Sponsor:
Lisa Sanderson Cox, PhD
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Bladder Cancer
Cervical Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
RATIONALE: A stop-smoking plan that includes health education counseling and bupropion may help African-American smokers stop smoking. It is not yet known whether health education counseling is more e...
Detailed Description
OBJECTIVES: Primary * To evaluate the efficacy of bupropion hydrochloride and health education counseling vs placebo and health education counseling for smoking cessation among African Americans who...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- African American who has smoked ≤ 10 cigarettes per day for ≥ 2 years AND has smoked for ≥ 25 days within the past month
- Not a heavy smoker
- No other forms of tobacco within the past 30 days
- Must be interested in stopping smoking
- No other smoker in the household enrolled in this study
- PATIENT CHARACTERISTICS:
- Has a home address and a functioning telephone number
- Not planning to move from the Kansas City metro area within the next 12 months
- Not pregnant or nursing
- Negative pregnancy test
- No alcohol or substance abuse within the past year
- Not currently drinking ≥ 14 alcoholic drinks per week
- No binge drinking (5 or more drinks on one occasion) on at least two occasions within the past month
- No history of seizures or head trauma
- No history of bulimia or anorexia nervosa
- No myocardial infarction within the past 30 days
- No reported use of opiates, cocaine, or stimulants
- No diabetes requiring oral hypoglycemics or insulin
- PRIOR CONCURRENT THERAPY:
- More than 30 days since prior nicotine replacement therapy, fluoxetine, clonidine, buspirone, or doxepin
- No other concurrent medication that contains bupropion hydrochloride
- No concurrent psychoactive medications
Exclusion
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
540 Patients enrolled
Trial Details
Trial ID
NCT00666978
Start Date
December 1 2007
End Date
June 1 2010
Last Update
November 13 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, United States, 66160-7357
2
Swope Health Central
Kansas City, Missouri, United States, 64130